What Researchers Did
Researchers evaluated the safety and preliminary outcomes of permanent iodine-125 brain stem implants in 10 children with central nervous system tumours, primarily brain stem gliomas, between 1988 and 1997.
What They Found
No surgical complications were reported with catheter placement for the iodine-125 implants. Four patients died within 7-9 months of diagnosis, while four patients remained alive for 5-38 months (median 10 months) post-diagnosis. Autopsies of two deceased patients showed progressive glioblastoma and necrosis, and one patient treated with an implant alone for midbrain low-grade astrocytoma showed necrosis without tumour after 36 months.
What This Means for Canadian Patients
This study suggests that permanent iodine-125 implants could be a safe treatment option for children with certain brain stem tumours, potentially offering a new approach for managing these challenging conditions. While preliminary, these findings may inform future treatment strategies and discussions between families and their healthcare providers regarding advanced therapies for paediatric central nervous system malignancies.
Canadian Relevance
This study was not conducted in Canada and does not have a direct Canadian connection.
Study Limitations
The study's main limitation is its small sample size of 10 patients and the preliminary nature of the reported outcomes.